API - Azelaic Acid, Dichloroacetic acid sodium salt (2015-02-13)
· Published by Health Canada · Official notice
Alert type: Drug Recall
Category: Drugs
Issue: Product Safety
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type II
| Lot or serial number | Brand name | Companies | Dosage form | DIN, NPN, DIN-HIM | Strength |
|---|
| All lots | API - Azelaic Acid, Dichloroacetic acid sodium salt | - Recalling Firm
- Xenex Laboratories Inc
- 2402 Canoe Ave,
- Coquitlam
- V3K 6C2
- British Columbia
- CANADA
- Marketing Authorization Holder
- Not Applicable
| Powder | N/A | N/A |
Recalled Products
API - Azelaic Acid, Dichloroacetic acid sodium salt
Lack of evidence product was fabricated specific to quality standard for drugs.
Wholesalers and compounding pharmacies